Medplus Health Peer Comparison
NSE: MEDPLUS | BSE: 543427
₹611.25
As on 17-Nov-2026 10:24IST
Market cap
₹7,441 Cr
Revenue (TTM)
₹7,587 Cr
P/E Ratio
35.3
P/B Ratio
3.6
Div. Yield
0 %
| Medplus Health | Gland Pharma | Laxmi Dental | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
7,441 | 55,759 | 1,096 | 66 | 31 |
Revenue (₹ Cr) |
7,587 | 7,072 | 294 | 21 | 152 |
Net Profit (₹ Cr) |
211.00 | 1,235.87 | 30.62 | 3.04 | 5.04 |
Net Margin (%) |
2.75 | 16.75 | 10.10 | 14.56 | 3.24 |
RoE (%) |
10.44 | 11.91 | 9.09 | 15.98 | 4.72 |
Price to Earnings |
35.26 | 45.12 | 33.85 | 21.54 | 13.53 |
Price-To-Book |
3.60 | 5.22 | 4.14 | 3.34 | 0.56 |
Income Statement (₹ Cr)
| Medplus Health | Gland Pharma | Laxmi Dental | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Operating Revenue
|
6,892.47 | 6,430.65 | 277.86 | 16.80 | 149.06 |
|
Total Income
|
6,963.79 | 6,746.98 | 286.40 | 16.93 | 151.31 |
|
Total Expenditure
|
6,268.09 | 4,801.11 | 233.97 | 14.47 | 140.44 |
|
EBITDA
|
624.38 | 1,629.54 | 43.89 | 2.34 | 8.62 |
|
Depreciation
|
282.87 | 423.67 | 15.88 | 0.81 | 3.24 |
|
EBIT
|
341.51 | 1,205.88 | 28.02 | 1.53 | 5.38 |
|
Interest
|
137.50 | 33.28 | 1.86 | 0.61 | 2.67 |
|
Other Income
|
71.32 | 316.33 | 8.55 | 0.12 | 2.24 |
|
Exceptional Items
|
-- | -24.35 | -5.78 | -- | -1.79 |
|
Profit before Tax
|
275.33 | 1,464.58 | 28.93 | 1.04 | 3.10 |
|
Provision for Tax
|
55.72 | 437.26 | 2.50 | 0.29 | 0.08 |
|
Profit after Tax
|
219.61 | 1,027.32 | 26.43 | 0.75 | 3.03 |
Liabilities (₹ Cr)
| Medplus Health | Gland Pharma | Laxmi Dental | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,975.36 | 10,357.95 | 243.32 | 13.78 | 52.83 |
|
Minority Interest
|
-0.71 | -- | 0.79 | 0.00 | 2.05 |
|
Non-Current Liabilities
|
1,225.00 | 482.17 | 14.83 | -0.07 | 10.02 |
|
Current Liabilities
|
763.90 | 1,608.40 | 30.79 | 8.87 | 71.19 |
|
Total Liabilities
|
4,084.80 | 12,448.52 | 300.10 | 23.05 | 136.09 |
Assets (₹ Cr)
| Medplus Health | Gland Pharma | Laxmi Dental | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,820.29 | 4,921.74 | 101.01 | 5.39 | 28.13 |
|
Current Assets
|
2,143.26 | 7,526.79 | 188.72 | 17.19 | 107.96 |
|
Total Assets
|
4,084.80 | 12,448.52 | 300.10 | 23.05 | 136.09 |
|
Total Debt*
|
0.00 | 243.36 | 0.00 | 5.07 | 11.66 |
|
Net Current Assets
|
1,379.36 | 5,918.38 | 157.93 | 8.32 | 36.77 |
|
Contingent Liabilities
|
14.06 | 10.12 | -- | 0.42 | 8.97 |
Cashflow (₹ Cr)
| Medplus Health | Gland Pharma | Laxmi Dental | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
495.58 | 1,031.39 | -5.00 | -0.01 | -3.81 |
|
Cash Flow from Investing Activities
|
-127.72 | 137.73 | -79.58 | -0.04 | 9.00 |
|
Cash from Financing Activities
|
-255.51 | -416.97 | -17.75 | 0.19 | -5.55 |
|
Net Cash Inflow / Outflow
|
112.36 | 752.14 | -102.33 | 0.14 | -0.35 |
Ratios
Profitability Ratios
| Medplus Health | Gland Pharma | Laxmi Dental | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
ROCE (%)
|
22.22 | 14.96 | 13.29 | 9.13 | 8.82 |
|
ROE (%)
|
11.93 | 10.56 | 11.95 | 5.59 | 5.77 |
|
ROA (%)
|
6.00 | 8.70 | 9.31 | 3.42 | 2.28 |
|
EBIT Margin (%)
|
10.09 | 30.26 | 18.87 | 14.64 | 7.29 |
|
Net Margin (%)
|
3.15 | 15.23 | 9.23 | 4.43 | 2.00 |
|
Cash Profit Margin (%)
|
7.19 | 22.56 | 15.23 | 9.27 | 4.20 |
Growth Ratios
| Medplus Health | Gland Pharma | Laxmi Dental | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
12.33 | 14.50 | 16.21 | -23.76 | 36.77 |
|
EBIT Growth (%)
|
26.01 | 31.25 | 14.03 | -59.17 | 848.46 |
|
Net Profit Growth (%)
|
46.18 | 47.07 | 4.16 | -77.67 | 142.76 |
|
EPS Growth (%)
|
45.68 | 47.07 | -8.79 | -77.67 | 117.30 |
|
Book Value Growth (%)
|
14.76 | 12.70 | 14.31 | 5.75 | 1.53 |
Valuation Ratios
| Medplus Health | Gland Pharma | Laxmi Dental | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Price / Earnings
|
45.79 | 27.22 | 29.86 | 29.91 | 21.72 |
|
Price / Book Value
|
5.11 | 2.71 | 3.67 | 1.63 | 0.50 |
|
Dividend Yield (%)
|
0.00 | 1.18 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
13.79 | 12.77 | 16.32 | 10.73 | 3.06 |
|
Market Cap (₹ Cr)
|
10,057.49 | 27,964.97 | 865.33 | 22.43 | 26.46 |
Solvency Ratios
| Medplus Health | Gland Pharma | Laxmi Dental | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.02 | 0.00 | 0.37 | 0.22 |
|
Short term debt to equity ratio
|
-- | -- | -- | 0.33 | 0.14 |
|
Current Ratio
|
2.81 | 4.68 | 6.13 | 1.94 | 1.52 |
|
Quick Ratio
|
1.00 | 3.60 | 5.42 | 1.15 | 0.75 |
|
Interest Coverage
|
3.00 | 45.01 | 16.57 | 2.71 | 2.16 |
Operating Efficiency Ratios
| Medplus Health | Gland Pharma | Laxmi Dental | Shree Pacetronix | GKB Ophthalmics | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.39 | 29.41 | 16.39 | 39.46 | 30.10 |
|
Asset Turnover
|
1.91 | 0.54 | 0.98 | 0.77 | 1.12 |
|
Receivable days
|
1.05 | 96.72 | 54.00 | 122.59 | 86.14 |
|
Inventory Days
|
71.25 | 97.32 | 26.54 | 138.71 | 128.56 |
|
Payable days
|
21.75 | 134.60 | 94.91 | 36.89 | 165.50 |
|
Cash Conversion Cycle
|
50.55 | 59.43 | -14.37 | 224.42 | 49.21 |